This move is archived. Current quotes and coverage live on the stock page.
Get LOVE alerts:
Cannara Biotech Inc. (LOVE.TO) saw its stock price drop by 2.67% in the last trading session, closing at CA$1.82. This decline raises concerns about the company's future in a tough market.
Investor takeaway: Investors should be cautious as Cannara's stock shows signs of weakness, especially with no recent positive news to boost confidence.
Advertisement
Cannara Biotech Inc.
LOVE.TO
LOVE.TO
Cannara Biotech Inc.
WealthAwesomeMarket cap
$196.58M
P/E
18.1x
52W high
$2.07
52W low
$1.55
1W change
+1.53%
Beta
0.36
Analyst Price Targets
Based on analyst covering LOVE · as of Sep 17, 2026
Wall Street analysts forecast LOVE stock price to rise 69.6% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.38
+69.6% Upside
Current Price
C$1.99
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on LOVE's historical volatility
30-Day Vol
19.4%
Annualized
90-Day Vol
29.4%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$2.38
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.11 | C$1.98 – C$2.26 |
| 60 trading days | C$2.24 | C$2.04 – C$2.46 |
| 90 trading days | C$2.38 | C$2.12 – C$2.67 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Cannara Biotech Inc. down 2.67% in one day
With a market cap of CA$181.76 million, Cannara is relatively small in the market, making it more vulnerable to fluctuations.
Bull case
Despite the recent decline, Cannara has secured exclusive rights to innovative technology that could improve its product offerings and strengthen its market position in the future.
Bear case
The recent performance of Cannara's stock reflects broader concerns about market volatility and the company's ability to stay profitable amid growing competition.
Recent Performance Overview
Advertisement
Cannara Biotech Inc. closed down 2.67% yesterday, highlighting investor uncertainty. Given its market cap of CA$181.76 million, the stock's volatility is a concern for potential investors. For more insights on Cannara's recent performance, check out our detailed analysis on LOVE.TO.
Market Context and Investor Sentiment
The drop in Cannara's stock price comes as small-cap companies face increased scrutiny in the broader market. Investors should consider the implications of Cannara's recent announcements, including its acquisition of Medican Organic Inc., as discussed in our latest updates on LOVE.TO.
Future Outlook
Looking ahead, Cannara's recent acquisition and technology rights could set the stage for future growth, but the current market sentiment suggests caution. For ongoing updates and expert analysis, follow our coverage on LOVE.TO.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
